Home
About
Publications Trends
Recent Publications
Expert Search
Archive
folate analogues
What Types of Cancer are Treated with Folate Analogues?
Folate analogues are used to treat a variety of cancers, including
acute lymphoblastic leukemia (ALL)
,
breast cancer
,
lung cancer
, and
osteosarcoma
. They are often part of combination chemotherapy regimens to enhance their effectiveness and reduce the likelihood of resistance.
Frequently asked queries:
What are Folate Analogues?
How Do Folate Analogues Work?
What Types of Cancer are Treated with Folate Analogues?
What are the Benefits of Using Folate Analogues in Cancer Treatment?
What are the Side Effects of Folate Analogues?
Are There Any Resistance Issues with Folate Analogues?
What are the New Developments in Folate Analogues?
How are Folate Analogues Administered?
When Should Reconstructive Surgery Be Considered?
Who is a Candidate for Endoscopic Treatment?
What is Security Software in Healthcare?
How Does Blood Protein Testing Work?
Can Inflammatory Cells Be Targeted for Cancer Therapy?
What are Emerging Trends in Cancer Research?
What Types of Cancer Information Can You Find?
How Does Perk Function in Cancer?
How Does Rheumatoid Arthritis Relate to Cancer?
What is the future outlook for cancer treatment?
How does siRNA work in Cancer treatment?
How Can One Reduce the Risk of Smog-Related Cancer?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe